Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.09
+0.09 (0.50%)
At close: Feb 13, 2026

HKG:1681 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
15,2196,7713,7803,1933,4952,439
Market Cap Growth
133.35%79.14%18.38%-8.64%43.27%-37.84%
Enterprise Value
11,3983,7881,2581,2252,1321,743
Last Close Price
18.097.773.913.033.132.04
PE Ratio
14.026.994.374.144.824.12
Forward PE
11.486.574.094.183.803.76
PS Ratio
4.252.141.331.211.391.17
PB Ratio
2.991.450.880.820.980.82
P/TBV Ratio
3.401.661.031.001.251.11
P/FCF Ratio
12.156.514.483.154.542.51
P/OCF Ratio
11.305.854.192.983.922.37
PEG Ratio
-0.700.700.700.700.70
EV/Sales Ratio
3.181.200.440.460.850.84
EV/EBITDA Ratio
9.213.451.271.382.382.37
EV/EBIT Ratio
9.703.651.381.512.632.67
EV/FCF Ratio
9.103.641.491.212.771.79
Debt / Equity Ratio
0.060.060.130.130.210.22
Debt / EBITDA Ratio
0.220.260.570.580.830.88
Debt / FCF Ratio
0.220.270.670.510.970.67
Net Debt / Equity Ratio
-0.81-0.82-0.78-0.75-0.62-0.55
Net Debt / EBITDA Ratio
-3.37-3.49-3.42-3.28-2.49-2.25
Net Debt / FCF Ratio
-3.31-3.68-4.01-2.88-2.89-1.70
Asset Turnover
0.560.520.500.510.490.46
Inventory Turnover
2.352.071.992.122.131.97
Quick Ratio
3.293.092.602.472.061.80
Current Ratio
3.543.322.862.682.252.00
Return on Equity (ROE)
23.60%22.07%21.38%21.53%21.64%19.98%
Return on Assets (ROA)
11.58%10.73%9.93%9.66%9.93%8.98%
Return on Invested Capital (ROIC)
113.06%106.82%88.13%67.03%50.16%34.89%
Return on Capital Employed (ROCE)
22.60%21.80%20.60%20.20%22.00%21.00%
Earnings Yield
7.26%14.31%22.87%24.18%20.73%24.28%
FCF Yield
8.23%15.37%22.34%31.73%22.03%39.84%
Dividend Yield
3.67%7.72%11.52%9.90%9.58%13.72%
Payout Ratio
45.94%74.75%41.59%18.67%33.56%26.36%
Buyback Yield / Dilution
-6.04%-4.12%-0.91%1.58%1.54%4.35%
Total Shareholder Return
-2.42%3.60%10.62%11.48%11.12%18.07%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.